Company profile for Philochem

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Philochem, a wholly owned subsidiary of Philogen, is the Discovery Unit of the Philogen group, based in Otelfingen, Zurich. Since 2006, it has pioneered innovations in ligand discovery and medicinal target identification. Key technologies include antibody isolation, immunocytokines, vascular marker discovery, and DNA-encoded chemical libraries. Integrated into drug discovery, top candidates advance to GMP production and clinic...
Philochem, a wholly owned subsidiary of Philogen, is the Discovery Unit of the Philogen group, based in Otelfingen, Zurich. Since 2006, it has pioneered innovations in ligand discovery and medicinal target identification. Key technologies include antibody isolation, immunocytokines, vascular marker discovery, and DNA-encoded chemical libraries. Integrated into drug discovery, top candidates advance to GMP production and clinical trials at Philogen. Philochem also actively collaborates with leading pharma companies through its cutting-edge platforms.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Switzerland
Address
Address
Libernstrasse 3, Otelfingen, 8112
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/06/10/3097201/0/en/Philochem-AG-Announces-the-Licensing-of-Worldwide-Rights-to-OncoACP3-a-novel-Radiopharmaceutical-Therapeutic-and-Diagnostic-Agent-targeting-Prostate-Cancer-to-RayzeBio-a-Bristol-My.html

GLOBENEWSWIRE
11 Jun 2025

https://www.globenewswire.com//news-release/2023/12/04/2789729/0/en/Philochem-and-Blue-Earth-Diagnostics-Announce-First-Three-Patients-Imaged-in-Phase-1-Clinical-Trial-of-68Ga-OncoFAP-68Ga-OncoFAP-DOTAGA-for-Diagnostic-Imaging-in-Solid-Tumors.html

GLOBENEWSWIRE
04 Dec 2023

https://www.prnewswire.com/news-releases/philochem-ag-seibersdorf-labor-gmbh-and-isotopia-announce-supply-development-and-manufacturing-agreements-301701535.html

PRNEWSWIRE
13 Dec 2022

https://www.globenewswire.com/news-release/2022/03/22/2407265/0/en/Philochem-and-Bracco-Imaging-Announce-a-Collaboration-on-the-Development-of-a-Small-Molecule-for-Diagnostic-or-Medical-Imaging-Applications.html

GLOBENEWSWIRE
22 Mar 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty